Home

Matthew R Patterson

CIK 1401018 · Chief Executive Officer · last filed 2025-05-23

Matthew R Patterson is a Chief Executive Officer who has filed 54 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for VOR, was dated May 23, 2025. Across all open-market trades the lifetime net is −$8.4M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

54

Lifetime Open-Market Net

-$8.41M

Filer Profile

Reported Address
C/O AMICUS THERAPEUTICS, INC.
6 CEDAR BROOK DRIVE
CRANBURY, NJ 08512
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VOR Director — $25.05 — $0 5 2025-05-23
FIXX Director — $12.65 — $0 6 2023-06-15
5:01 Acquisition Corp. (FVAM) Delisted Director — $10.00 — $0 1 2020-10-20
BOLD Chief Executive Officer 0 $2.87 $0 -$7.92M 21 2020-01-15
AMICUS THERAPEUTICS, INC. (FOLD) Delisted Acting CEO & President 106,547 $14.49 $1.54M -$489.4K 21 2011-04-19

Recent Filings

54 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-05-23 VOR Grant (A) — $0 EDGAR
2024-05-28 VOR Grant (A) — $0 EDGAR
2023-06-15 FIXX Grant (A) — $0 EDGAR
2023-06-02 VOR Grant (A) — $0 EDGAR
2022-06-17 FIXX Grant (A) — $0 EDGAR
2022-06-16 VOR Grant (A) — $0 EDGAR
2021-06-22 FIXX Grant (A) — $0 EDGAR
2021-02-09 VOR Grant (A) — $0 EDGAR
2020-10-20 5:01 Acquisition Corp. (FVAM) Delisted Other (J) — $0 EDGAR
2020-06-12 FIXX Grant (A) — $0 EDGAR
Showing 1–10 of 54
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.